Active Biotech AB is a Swedish biotechnology company focused on the research and development of pharmaceuticals and vaccines. Their core competence is knowledge of the human immune system.
Recent Publications by Active Biotech: |  |
Increased degradation rate of nitrososureas in media containing carbonate.
The stability of two nitrosoureas, tauromustine and lomustine, has been... | 8th October, 2009
| Department of Preclinical Development, Active Biotech Research AB, P.O.
| In Vitro Cell Dev Biol Anim. 2009 Jan-Feb;45(1-2):32-4. Epub 2008 Oct 15.
DOI Direct Link |
Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides.
Despite more than 25 years of research, the molecular targets of... | 1st July, 2009
| Active Biotech AB, Lund, Sweden.
| PLoS Biol. 2009 Apr 28;7(4):e97.
DOI Direct Link |
Immunotherapy with tumor-targeted superantigens (TTS) in combination with docetaxel results in synergistic anti-tumor effects.
In this study we explored the possibility of combining immunotherapy... | 5th May, 2009
| Active Biotech Research AB, Lund, Sweden.
| Int Immunopharmacol. 2009 Aug;9(9):1063-70. Epub 2009 May 3.
DOI Direct Link |
Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.
In this study we explored the possibility of improving the anti-tumor... | 9th April, 2008
| Active Biotech Research AB, P.O. Box 724, SE-220 07 Lund, Sweden.
| Int Immunopharmacol. 2008 Mar;8(3):442-52. Epub 2007 Dec 7.
DOI Direct Link |
Discovery of selective small-molecule CD80 inhibitors.
Protein-protein interactions are widely found in biological systems... | 19th August, 2007
| Active Biotech Research AB, Lund, Sweden.
| J Biomol Screen. 2007 Jun;12(4):464-72. Epub 2007 Apr 13.
DOI Direct Link |
→View more Active Biotech research publications. |
This page has been viewed 529 times since April 2007, the link to the organisation's website has been followed 111 times